Earlier access to subsidised CAR T-cell therapy for lymphoma
More patients with aggressive blood cancers can now access subsidised CAR T-cell therapy thanks to a change to eligibility criteria nationally, and Peter Mac patients are among the first to benefit.
Previously, patients with... Read more